Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Jacomm /Pharma aktiebolaget
AB
Active
Org 5590105267
Bragevägen 24
Retail sale of pharmaceutical products · NACE 4773
Est. 2015
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 14,7M
+15% vs 2023
EBITDA margin
3.5%
+431% vs 2023
Equity ratio
16.5%
Financial strength
Net profit 2024
SEK 299K
+5083% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
0M
-100%
2021
1M
+100%
2022
0M
-100%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
SEK 14,7M
+15%
EBITDA
SEK 519K
+431%
Net profit
SEK 299K
+5083%
Total assets
SEK 4,7M
-13%
Equity
SEK 772K
+63%
Employees
3
—
Company information
Legal name
Jacomm /Pharma aktiebolaget
Org number
5590105267
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15 april 2015
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Öppenvårdsapotek.
Contact
Address
Bragevägen 24
Email
info@apotekbrunnsang.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Botkyrka
All Sweden companies
Revenue
SEK millions
0M
4M
9M
13M
17M
12M
2020
12M
2021
13M
2022
13M
2023
15M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
1M
2022
0M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
11 665
12 106
13 398
12 807
14 717
Staff expenses
—
—
—
—
—
EBITDA
599
421
931
−157
519
Depreciation & amort.
−11
−11
−11
−23
−12
EBIT
588
410
920
−180
507
Net financials
−46
−41
−37
−41
−35
Profit before tax
406
276
749
1
382
Tax
−88
−58
−156
−7
−83
Net profit
318
218
593
−6
299
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
4 515
4 643
5 324
5 389
4 676
Equity
1 668
886
1 479
474
772
Long-term debt
925
890
835
795
760
Short-term debt
1 239
2 091
2 099
3 432
2 364
Total debt
2 164
2 981
2 934
4 227
3 124
Financial ratios
5-year trend
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
2020
2024
Equity ratio
16.5%
This company
38.2%
Market median
-57% vs market
2020
2024
Return on equity
38.7%
This company
18.4%
Market median
+110% vs market
2020
2024
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
2020
2024
Asset turnover
3.15×
This company
1.12×
Market median
+181% vs market
2020
2024
Debt / equity
5.06×
This company
0.62×
Market median
-716% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SK
Sara Katarina Nyberg
Audit
Audit
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MT
Maria Tova M Lindholm Malekkhaiat
Deputy Board Member
2022
MM
Mohammad Malekkhaiat
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Jacomm /Pharma aktiebolaget also hold positions in
0
other companies.
Person
Role here
Other companies
Sara Katarina Nyberg
Audit
0 companies
Maria Tova M Lindholm Malekkhaiat
Deputy Board Member
0 companies
Mohammad Malekkhaiat
Board of Directors
0 companies